- Your Heart
- Ask Dr. T
- Heart Healthy Living
- About Us
- Contact Us
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
During an extended-follow-up of up to 15 years, VA patients had similar survival rates between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease. In an article, published in the NEJM of 11/12/2015,
In the COURAGE trial, the authors compared an initial management strategy of optimal medical therapy alone with optimal medical therapy plus PCI among patients with stable ischemic heart disease and found no significant difference between the treatment groups with respect to the composite primary end point of death from any cause or nonfatal myocardial infarction or with respect to any of the other cardiac end points (including death from any cause or hospitalization for acute coronary syndrome) during a median follow-up period of 4.6 years.
In the current study, extended survival analysis failed to show a long-term survival benefit from initial PCI among the patients with stable ischemic heart disease who were followed for up to 15 years after initial enrollment in the COURAGE trial.
These data are competable with other published articles that have failed to show a survival benefit associated with PCI interventions for stable coronary artery disease.
From: Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N Engl J Med 2015; 373:1937-1946
Ask Doctor T. Blog
I have been advised by my primary physician to schedule a cardiac catherization and possible stent placement procedure after having a Nuclear Stress Test with the following "Findings:
The study quality is excellent. There is no transient LV ischemic dilatation noted. The left ventricular...
I have a friend with internal defibulator. can I perform cpr and is it possible for me to get shocked if the debibulator is going off?